Tenet Healthcare Corporation (THC) Stock Price & How to Invest

Last updated November 2026

Short answer

You can invest in Tenet Healthcare (THC) by buying shares or fractional shares at any major broker, through a healthcare or S&P 500 ETF that holds it, or as one holding in a thematic basket. Tenet is a for-profit healthcare operator that runs acute care hospitals and, through its United Surgical Partners International (USPI) unit, the largest ambulatory surgery center platform in the United States. The stock has re-rated as USPI outpatient growth, margin expansion, and steady debt reduction have improved earnings quality. As of November 20, 2026 the shares closed at $262.86, up about 32% year to date, for a market cap around $20.9 billion and a trailing P/E near 8x.

THC stock price

As of 2026-11-20, Tenet Healthcare Corporation (THC) last closed at $263.19, up 37.1% over the past year. Over the past 52 weeks it has traded between $161.37 and $292.97.

THC last close
$263.19
1 day
-0.15%
1 month
-2.21%
1 year
+37.11%
52-week range
$161.37 to $292.97
Last close
2026-11-20

Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Tenet Healthcare Corporation's investor relations page. Walnut is informational, not investment advice.

THC key stats

At $263.19 on November 20, 2026, Tenet Healthcare Corporation (THC) has a market cap of $20.9B and a P/E of 7.7 on trailing earnings (12.9 on forward earnings).

Market cap
$20.9B
P/E (trailing)
7.7
P/E (forward)
12.9
EPS (trailing 12 months)
$34.31
Price to book
3.9
Beta
1.20

Market cap, P/E and yield are measured at the $263.19 price on November 20, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with Tenet Healthcare Corporation (THC)?

The last two weeks for Tenet Healthcare Corporation, as of November 22, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • THC closed at $263.19 on November 20, 2026, down 8.0% over the past five trading days (from $286.03).

Tenet Healthcare Corporation filed no current, quarterly or annual report with the SEC in the last two weeks.

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

Tenet Healthcare Corporation (THC) latest quarter

Tenet Healthcare reported revenue of $5.6 billion for Q3 2026, up 6% from a year earlier (Tenet Healthcare, Oct 29, 2026).

Revenue
$5.6 billion
up 6% from a year earlier
Diluted EPS (GAAP)
$12.41
up 222% from a year earlier
Hospital Operations and Services
$4.3 billion
up 6% from a year earlier

Source: Tenet Healthcare Q3 2026 results, Oct 29, 2026. Full earnings breakdown

What does Tenet Healthcare Corporation (THC) do?

Tenet Healthcare is a diversified for-profit healthcare services company that operates through three segments. Hospital Operations runs acute care and specialty hospitals plus affiliated outpatient facilities, imaging centers, and physician practices. United Surgical Partners International (USPI) is the ambulatory segment and operates or holds interests in hundreds of ambulatory surgery centers and surgical hospitals across dozens of states, making it the largest ASC platform in the country. Conifer Health Solutions provides revenue cycle management and value-based care services to hospitals and health systems.

The investment story has shifted toward USPI, which benefits from the secular migration of surgical procedures out of expensive inpatient settings into lower-cost outpatient centers. USPI carries higher margins and grows faster than the hospital base, and Tenet has been acquiring additional surgery centers to expand it. Alongside that mix shift, management has cut debt, reduced interest expense, and earned credit-rating upgrades, which has lifted earnings per share and supported the stock. Founded in 1969 and headquartered in Dallas, Texas, Tenet trades on the NYSE and is a member of the S&P 500.

The 2026 numbers have kept beating expectations. Third-quarter revenue, reported on October 29, was about $5.63 billion, up roughly 6.5% year over year and level with the second quarter, and adjusted EPS of $6.64 came in far above the roughly $4.68 consensus, the fifth consecutive quarterly beat after $6.12 against $4.26 in the second quarter. Net income attributable to Tenet reached about $1.0 billion in the third quarter, up from about $826 million in the second. Over the trailing twelve months revenue is about $22.2 billion and net income about $2.9 billion, which puts the trailing P/E near 7.7x. Analysts now expect about $22.53 of EPS for 2026 and about $20.36 for 2027, a decline of roughly 10%, which is why the forward P/E of about 12.9x sits well above the trailing figure. The stock reached a 52-week high of about $301 after the October report, then eased: THC closed at $262.86 on November 20, 2026, up about 32% year to date and 41% over one year, though down about 2% over the past month and 3% over three months.

What's driving Tenet Healthcare Corporation (THC)?

1. USPI ambulatory surgery leadership.

United Surgical Partners International is the largest ambulatory surgery center platform in the United States, with interests in more than 500 surgery centers and over two dozen surgical hospitals. USPI grows faster and at higher margins than the hospital base and rides the multi-year shift of procedures from inpatient to outpatient settings. Same-facility surgical revenue and net revenue per case have been growing at healthy rates.

2. Business mix shift toward higher-margin services.

Tenet has sold hospitals and reinvested in USPI, tilting the revenue mix toward the higher-margin ambulatory business. This mix shift, combined with disciplined expense management and acquisitions of new centers, has expanded consolidated EBITDA margins well above historical hospital-operator norms.

3. Deleveraging and improved earnings quality.

Management has prioritized reducing debt, cutting interest expense, and returning capital through buybacks. Sustained deleveraging and EBITDA strength have driven credit-rating upgrades, and lower interest expense has compounded strong earnings-per-share growth over the past two years. Debt remains substantial at about $13.24 billion against about $2.67 billion of cash as of September 30, 2026, but trailing EBITDA of about $5.13 billion and free cash flow of roughly $2.03 billion give the company room to keep paying it down and repurchasing shares. Cash rose by about $500 million from mid-year.

4. Conifer revenue cycle services.

Conifer Health Solutions provides revenue cycle management, patient communications, and value-based care support to hospitals and health systems, including Tenet's own facilities and third-party clients. It is a smaller, steadier services contributor that diversifies Tenet away from pure patient-care revenue.

What are the risks to Tenet Healthcare Corporation (THC)?

Hospital operators face reimbursement pressure from Medicare, Medicaid, and commercial payers, and changes to Affordable Care Act exchange subsidies could pressure volumes and payer mix. Labor costs, physician and nurse staffing, and wage inflation weigh on the hospital segment. The company still carries meaningful debt despite deleveraging, about $13.2 billion at the end of September 2026, so higher-for-longer interest rates matter. Bad debt from uninsured and underinsured patients, regulatory and billing scrutiny, and cyclicality in elective surgical volumes are additional risks; peer Community Health Systems said in November 2026 that it sees patients delaying surgeries into next year as costs squeeze them. Acquisition-led USPI growth depends on continued access to attractive surgery-center deals at reasonable prices. After a roughly 32% gain in 2026, expectations are higher too: consensus calls for 2027 EPS of about $20.36, about 10% below the roughly $22.53 expected for 2026, so the market is not pricing in another year of earnings growth, and a stumble against that bar could weigh on the shares. The trailing P/E near 8x also flatters the stock, because the trailing $2.9 billion of net income runs well ahead of what analysts expect to recur.

What is the Tenet Healthcare Corporation (THC) forecast?

22 analysts publish price targets on THC, averaging $308.91 as of November 2026, or +17.4% against the $263.19 share price on November 20, 2026. The published targets run from $265.00 to $342.00, a narrow spread, and the ratings split 19 buy, 4 hold, 0 sell. Over the last six months there have been 9 raises and 1 cut among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full THC forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

Is THC a buy or a sell?

We give no verdict on Tenet Healthcare Corporation. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. USPI ambulatory surgery leadership. United Surgical Partners International is the largest ambulatory surgery center platform in the United States, with interests in more than 500 surgery centers and over two dozen surgical hospitals. The most optimistic published target, $342.00, assumes this works close to its best case.

The case against. Hospital operators face reimbursement pressure from Medicare, Medicaid, and commercial payers, and changes to Affordable Care Act exchange subsidies could pressure volumes and payer mix. The most pessimistic target, $265.00, is roughly what THC is worth if this bites instead.

Read the full bull and bear case on THC, including what would have to change to break either one. Walnut is not an investment adviser.

Has Tenet Healthcare Corporation (THC) split its stock?

No. Tenet Healthcare Corporation (THC) has not split its stock in the last 10 years. The statement covers only the window we check, so an older split in the company’s history is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

How is Tenet Healthcare Corporation (THC) valued?

Market cap, P/E and dividend yield at today's price are in the THC key stats above. The business figures below come from Tenet Healthcare Corporation's reported results as of November 2026 and change when it next reports.

  • Revenue (TTM): ~$22.2 billion (Q3 2026 +~6.5% yoy)
  • Q3 2026 adjusted EPS: ~$6.64 vs ~$4.68 est.
  • Net income (TTM): ~$2.9 billion (net margin ~13%)
  • Operating margin (TTM): ~19%

As of November 2026: Tenet still trades at a modest earnings multiple typical of hospital operators (a discount that prices in reimbursement and leverage risk), even after a 32% rise in 2026 as USPI mix shift, margin gains, and deleveraging improved earnings quality. The forward P/E near 12.9x sits well above the trailing 7.7x because analysts expect 2027 EPS of about $20.36, down from about $22.53 in 2026, after a run of large beats. Fourth-quarter consensus is about $5.24 of EPS on $5.67 billion of revenue, and the average of 22 analyst targets is about $309.

Which ETFs hold Tenet Healthcare Corporation (THC)?

If you want THC exposure as part of a larger bundle, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

ETFName% in THCExpense ratio
MDYState Street SPDR S&P MidCap 400 ETF Trust0.61%0.23%
IJHiShares Core S&P Mid-Cap ETF0.6%0.05%
SCHMSchwab U.S. Mid-Cap ETF0.45%0.03%
VBRVanguard Morningstar Small-Cap Value ETF0.5%0.05%
SPMDState Street SPDR Portfolio S&P 400 Mid Cap ETF0.6%0.03%
IJKiShares S&P Mid-Cap 400 Growth ETF1.3%0.17%
IVOOVanguard S&P Mid-Cap 400 Index Fund ETF Shares0.6%0.07%

Who competes with Tenet Healthcare Corporation (THC)?

For-profit hospital operators

HCA Healthcare (HCA) is the largest US for-profit hospital company and the primary large-cap peer. Community Health Systems (CYH) and Universal Health Services (UHS) are the other publicly traded acute care hospital operators. These names compete with Tenet's Hospital Operations segment for patient volumes, physician relationships, and payer contracts in overlapping markets.

Ambulatory surgery and outpatient care

Surgery Partners (SGRY) is the closest public comparable to Tenet's USPI ambulatory surgery business. HCA also operates a large ambulatory surgery footprint. The outpatient surgical shift is the shared growth driver, so competition centers on acquiring centers and recruiting surgeons.

Healthcare revenue cycle services

Tenet's Conifer unit competes with revenue cycle management and health-services firms such as R1 RCM and other outsourced hospital-services providers for revenue cycle, patient engagement, and value-based care contracts.

What stocks are similar to Tenet Healthcare Corporation (THC)?

Other names that sit close to THC: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.

How to invest in Tenet Healthcare Corporation (THC)

There are three common ways to get THC exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (MDY, IJH, SCHM), which spreads the position across many companies. Or build it into a focused thematic portfolio, so THC sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where THC fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

The bottom line on Tenet Healthcare Corporation (THC)

Tenet Healthcare (THC) is a hybrid hospital and ambulatory surgery operator whose value increasingly rests on the high-growth, higher-margin USPI surgery center business rather than the legacy acute care hospitals. In a portfolio it behaves as a healthcare-services and hospital cyclical holding leveraged to outpatient surgical volumes, payer mix, and continued deleveraging. A fifth straight earnings beat in the third quarter of 2026 has not lifted the shares further: they sit about 13% below their 52-week high, as analysts expect EPS to fall in 2027.

More on Tenet Healthcare Corporation (THC)

Whether THC is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is THC a buy or a sell?, and where the stock could go from here in the THC stock forecast.

For income investors, whether THC pays a dividend and how the payout looks is covered in does THC pay a dividend? And to weigh THC against a peer, read the full side-by-side comparisons: THC vs HCA and THC vs UHS.

Wondering how THC fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Tenet Healthcare Corporation

Ask Walnut's AI anything about THC and see how it fits what you own.

FAQ

What is Tenet Healthcare's ticker symbol?

+

THC, listed on the New York Stock Exchange. Officially Tenet Healthcare Corporation, founded in 1969 and headquartered in Dallas, Texas. It trades during US market hours and is available at every major US brokerage, including as fractional shares at brokers that support them.

What does Tenet Healthcare do?

+

Tenet is a for-profit healthcare services company with three segments. Hospital Operations runs acute care and specialty hospitals plus affiliated outpatient facilities. United Surgical Partners International (USPI) operates the largest ambulatory surgery center platform in the United States. Conifer Health Solutions provides revenue cycle management and value-based care services to hospitals.

Who are Tenet Healthcare's competitors?

+

In hospitals, the main peers are HCA Healthcare, Community Health Systems, and Universal Health Services. In ambulatory surgery, Surgery Partners is the closest public comparable to USPI, and HCA also runs a large outpatient footprint. In revenue cycle services, Conifer competes with firms such as R1 RCM.

Is Tenet Healthcare in the S&P 500?

+

Yes. Tenet Healthcare is a member of the S&P 500 and is included in broad US and healthcare sector indices. That means index funds tracking the S&P 500, and healthcare-focused ETFs, hold THC as one of their constituents.

Does Tenet Healthcare pay a dividend?

+

No. Tenet does not currently pay a dividend and has prioritized reducing debt and repurchasing shares as its capital allocation strategy. Given the focus on deleveraging and reinvesting in the USPI ambulatory surgery business, dividend initiation has not been a near-term priority.

What is USPI and why does it matter to Tenet?

+

United Surgical Partners International (USPI) is Tenet's ambulatory segment and the largest ambulatory surgery center platform in the United States, with interests in more than 500 surgery centers and over two dozen surgical hospitals. USPI grows faster and at higher margins than the hospital base and benefits from the shift of procedures to outpatient settings, so it is the primary driver of Tenet's earnings growth.

Which ETFs hold Tenet Healthcare?

+

As an S&P 500 member, THC is held by broad index funds such as VOO and SPY at small weights. Healthcare sector ETFs like XLV (Health Care Select Sector SPDR) and healthcare providers or hospital-themed funds hold THC at somewhat higher weights. For meaningful THC exposure given its mid-cap size, the sector-fund weights are still small relative to direct ownership.

What is Tenet Healthcare's market cap and valuation?

+

Tenet's market cap is roughly $20.9 billion as of November 20, 2026, at a share price of $262.86. On trailing earnings the stock trades at about 7.7x, and about 12.9x forward consensus EPS, a typical range for hospital operators that has expanded as USPI mix shift, margin gains, and debt reduction improved earnings quality. The gap between the two reflects analyst expectations that EPS will fall in 2027. EV/EBITDA is about 7.0x.

How did Tenet Healthcare do in its latest quarter?

+

In the third quarter of 2026, reported on October 29, Tenet posted revenue of about $5.63 billion, up roughly 6.5% year over year, and adjusted EPS of $6.64 against a consensus of about $4.68, its fifth straight quarterly beat. Net income attributable to the company was about $1.0 billion, up from about $826 million in the second quarter, when adjusted EPS was $6.12 against $4.26. Fourth-quarter consensus is near $5.24 of EPS on $5.67 billion of revenue.

How has THC stock performed in 2026?

+

As of the November 20, 2026 close of $262.86, Tenet shares were up about 32% year to date and about 41% over one year, but down about 2% over the past month and 3% over three months, within a 52-week range of roughly $158 to $301. The average of 22 analyst targets is about $309. Walnut is not an investment adviser, and these figures describe past performance only.

Why do analysts expect Tenet's earnings to fall in 2027?

+

Consensus calls for about $22.53 of EPS in 2026 and about $20.36 in 2027, a decline of roughly 10%, even though revenue is expected to edge up to about $22.5 billion. Tenet has beaten estimates in five straight quarters, and 2026 profit has run well above prior years (about $2.9 billion of trailing net income against about $1.41 billion in 2025). Analysts are treating part of that as unlikely to repeat, alongside sector pressures such as ACA exchange subsidy changes and delayed elective surgery.

Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Tenet Healthcare Corporation's investor relations page or your broker before making investment decisions.